Editorial: Hypoxia and angiogenesis in cancer

Front Pharmacol. 2024 Aug 13:15:1448204. doi: 10.3389/fphar.2024.1448204. eCollection 2024.

¹ Student Research Committee, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
² The Ohio State University Wexner Medical Center and OSU Comprehensive Cancer Center, Columbus, OH, United States.
³ Laboratory of Immunology and General Pathology, Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy.
⁴ Unit of Molecular Pathology, Biochemistry and Immunology, IRCCS MultiMedica, Milan, Italy.
⁵ Rumbaugh-Goodwin Institute for Cancer Research, Nova Southeastern University, Fort Lauderdale, FL, United States.
⁶ Molecular Dermatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

No abstract available

Keywords: HIF; VEGF; VEGFR; angiogenesis; cancer; hypoxia; signaling pathways.

Publication types

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.